Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer. [electronic resource]
Producer: 20021217Description: 87-92 p. digitalISSN:- 0022-4790
- Aged
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Combined Modality Therapy
- Dihydrouracil Dehydrogenase (NADP)
- Drug Combinations
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Oxidoreductases -- metabolism
- Postoperative Care
- Prognosis
- Retrospective Studies
- Survival Analysis
- Tegafur -- therapeutic use
- Treatment Outcome
- Uracil -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.